向NLRP3通过诱导PERK/eIF2介导的亡来抑制AML的进展
Michela Luciano1,2, Helene Sieberer1,3, Peter W Krenn1,3
1Department of Biosciences and Medical Biology, Paris-Lodron University Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
Cell communication and signaling : CCS
|September 2, 2024
概括
通过激活PERK/eIF2轴,NLRP3炎症酶驱动急性髓性白血病 (AML) 细胞存活率. 抑制这种途径,特别是NLRP3,为AML治疗提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 是一种异质癌症,具有具有挑战性的治疗结果.
- 越来越多地认识到NLRP3炎症酶在AML病变发生中的作用,但尚未完全理解.
研究的目的:
- 调查NLRP3炎症酶在AML病原和生存中的作用.
- 探索针对NLRP3途径用于AML治疗的潜力.
主要方法:
- 对AML患者NLRP3炎症组基因表达的公共基因组数据集的分析.
- 用CRISPR/Cas9技术产生NLRP3缺乏的AML细胞,用于功能研究.
- 在小鼠模型中进行蛋白质学和体内研究,以阐明NLRP3的致病机制.
主要成果:
- 增加NLRP3表达与AML患者的整体存活率降低相关.
- 删除或抑制NLRP3会诱导细胞亡,并降低AML细胞存活率.
- 缺乏NLRP3会通过PERK/eIF2途径改变蛋白质翻译,从而影响细胞亡.
结论:
- NLRP3/PERK/eIF2轴是AML细胞存活的一个新型驱动器.
- 针对NLRP3及其下游信号通路,为AML提供了潜在的治疗策略.
- 了解NLRP3炎症酶的作用可能会改善AML患者的预后和治疗.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


